Advanced Biomed (ADVB) Gains from Investment Securities (2024 - 2026)

Advanced Biomed's (ADVB) quarterly Gains from Investment Securities came in at -$1297.0 in Q1 2026, down 119.63% quarter-over-quarter from $6608.0 in Q4 2025.

Advanced Biomed (ADVB) Gains from Investment Securities (2024 - 2026) Analysis & Trends

Advanced Biomed has disclosed Gains from Investment Securities across 3 years of filings, most recently posting -$1297.0 for Q1 2026.

  • Gains from Investment Securities for Q1 2026 came in at -$1297.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$12501.0 (changed N/A YoY), and the FY2025 annual result was $83027.0, up 247.93% from the prior year.
  • Gains from Investment Securities came in at -$1297.0 for Q1 2026 at Advanced Biomed, down from $6608.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $6608.0 in Q4 2025 to a low of -$9555.0 in Q2 2024.
  • The 3-year median for Gains from Investment Securities is -$1297.0 (2026), against an average of -$2582.0.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 30,010.71 Bn 30,010.25 Bn 1.11 Bn
2 Thermo Fisher Scientific 179.46 Bn 176.21 Bn 7.74 Bn
3 Danaher 130.33 Bn 124.64 Bn 3.59 Bn
4 Idexx Laboratories 44.44 Bn 44.24 Bn 722.74 Mn
5 Agilent Technologies 37.27 Bn 35.46 Bn 990.00 Mn
6 Iqvia Holdings 30.70 Bn 28.73 Bn 1.36 Bn
7 Natera 30.59 Bn 29.49 Bn 696.04 Mn
8 Illumina 24.86 Bn 23.71 Bn 721.00 Mn
9 Mettler Toledo International 23.06 Bn 23.00 Bn 555.82 Mn
10 Advanced Biomed - - -

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,297.00
Mar 31, 2026 -1,297.00
Dec 31, 2025 6,608.00
Dec 31, 2025 6,608.00
Sep 30, 2025 -8,257.00
Sep 30, 2025 -8,257.00
Jun 30, 2024 -9,555.00
Jun 30, 2024 -9,555.00
Mar 31, 2024 -409.00
Mar 31, 2024 -409.00